tirzepatide surmount 5 Mean percent weight loss change was 21.6% with #tirzepatide vs. 15.4% with #semaglutide in SURMOUNT-5. https://t.co/8qpOL9Ze25 SURMOUNT-5: Tirzepatide Bests Semaglutide in
Description
Amongst, overweight and obese patients defined by BMI in 2024 (58.9% [95% CIs 53.3-64.2%] female [182/309], median [IQR] age 56.6 [46.2-66.1]) GLP 1RA use has increased from 3.2% (10/309 [95% CIs 1.8-5.9%]) to 13.6% (42/309 [95% CIs 10.2-17.9%] [p=7.1x10-6])
Do not apply heat directly over the patch
Learn the key differences in weight loss results and how these powerful medications work from a board-certified surgeon
Explore medically supervised weight loss with semaglutide in Annapolis, MD at Sandel Duggal
